Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.

Market Analysis and Insights: Global Amlodipine Besilate Market
The global Amlodipine Besilate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Amlodipine Besilate Scope and Market Size
The global Amlodipine Besilate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine Besilate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity≥99%

Segment by Application
Amlodipine Besilate Tablets
Amlodipine Besilate Capsule

The Amlodipine Besilate market is analysed and market size information is provided by regions (countries). Segment by Application, the Amlodipine Besilate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Arch Pharmalabs
Century Pharmaceutical
VPL Chemicals
Rakshit Drugs
Moehs
Dr. Reddy's
Cadila Pharmaceuticals
Amsal Chem
Changzhou Yabang Pharmaceutical
Cipla
Tapi Teva
Suanfarma